Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Culver DA, Bonella F, Gupta R, Spagnolo P, Veltkamp M, Cameli P, Restrepo CI, Frye BC, Kameda M, Cifrián-Martínez J, Ali H, Aryal S, Carmona EM, Nunes H, Obi ON, Hart SP, Sellarés J, Azuma A, Grutters JC, Kinnersley N, Niranjan V, Baughman RP

Open source

DOI
10.1016/s2213-2600(26)00283-3
Published
2026 Oct 26
Container
The Lancet. Respiratory medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-26-00283-3,
  title = {Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.},
  author = {Culver DA and Bonella F and Gupta R and Spagnolo P and Veltkamp M and Cameli P and Restrepo CI and Frye BC and Kameda M and Cifrián-Martínez J and Ali H and Aryal S and Carmona EM and Nunes H and Obi ON and Hart SP and Sellarés J and Azuma A and Grutters JC and Kinnersley N and Niranjan V and Baughman RP},
  year = {2026},
  journal = {The Lancet. Respiratory medicine},
  doi = {10.1016/s2213-2600(26)00283-3},
  url = {https://doi.org/10.1016/s2213-2600(26)00283-3}
}

RIS

TY  - JOUR
TI  - Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
AU  - Culver DA
AU  - Bonella F
AU  - Gupta R
AU  - Spagnolo P
AU  - Veltkamp M
AU  - Cameli P
AU  - Restrepo CI
AU  - Frye BC
AU  - Kameda M
AU  - Cifrián-Martínez J
AU  - Ali H
AU  - Aryal S
AU  - Carmona EM
AU  - Nunes H
AU  - Obi ON
AU  - Hart SP
AU  - Sellarés J
AU  - Azuma A
AU  - Grutters JC
AU  - Kinnersley N
AU  - Niranjan V
AU  - Baughman RP
PY  - 2026
JO  - The Lancet. Respiratory medicine
DO  - 10.1016/s2213-2600(26)00283-3
UR  - https://doi.org/10.1016/s2213-2600(26)00283-3
ER  - 

APA

DA, C., F, B., R, G., P, S., M, V., P, C., CI, R., BC, F., M, K., J, C., H, A., S, A., EM, C., H, N., ON, O., SP, H., J, S., A, A., JC, G., N, K., V, N., & RP, B. (2026). Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.. The Lancet. Respiratory medicine. https://doi.org/10.1016/s2213-2600(26)00283-3

Source records